Breaking
Saturday, June 13, 2026

Clinical Trials

🇺🇸 FDA Page 9

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.

Showing 97–108 of 380 articles

High impact AnalysisJun 2, 2026

AbiVax falls as safety worries cloud ‘landmark’ immune drug results

FDA · ulcerative colitis · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Personalized mRNA Cancer Vaccines: A New Era for Melanoma Treatment

melanoma · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Understanding Computer Software Assurance (CSA) and Its Benefits for Pharma

FDA · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Oncology Draft Guidance: Reducing Animal Testing for Cancer Drugs

FDA · oncology · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Kardigan's IPO Plans: Fueling the Next Wave of Cardiovascular Drug Development

heart disease · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Top Biotech Penny Stocks to Watch in 2026: A Strategic Outlook

10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Biotech Movers: Moderna, Iovance, ALHC, and Summit Therapeutics in Focus

Ebola · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Eli Lilly's 340B Data Mandate: A New Tactic in Pharma's Discount Program Battle

8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Eli Lilly's Retatrutide Success Amidst Regulatory Shifts: A Strategic Analysis

FDA · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Immunovant's IMVT-1402 Shows Blockbuster Potential in Autoimmune Disease; Wave Life Sciences Advances RNA Editing

FDA · autoimmune disease · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Cracks Down on Illegal Tobacco Products Disguised as Everyday Items

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Wave Life Sciences' Monthly Dosing Strategy for AATD: A Competitive Analysis

FDA · AATD · 10 min

Dr. Sarah Mitchell